Historically, the difficulty of conceiving has been mainly associated with women; however, current statistics show that the male factor is present in 50% of infertility diagnoses. In the case of a male factor, Artificial Insemination emerges as an accessible and safe assisted reproduction technique, especially indicated for couples with mild or moderate alterations in seminal quality. The process begins with a thorough andrological evaluation and a semen analysis to determine the viability of the treatment. Once follicular maturity is reached, the insemination is scheduled, which is performed on an outpatient basis and without the need for anesthesia, allowing the patient to resume her daily activities immediately. This low-complexity procedure consists of depositing a sperm sample, previously optimized in the laboratory, directly into the woman's uterus to facilitate natural fertilization. Dr. Saúl Barrera, Medical Director of IVI Panama, emphasizes that sample preparation is critical for success, using sperm training techniques that select sperm with the best motility and health. In cases of greater complexity, IVI Panama employs tools such as MACS (selection of sperm with better quality) to enhance the chances of pregnancy. Beyond the clinical intervention, the institution highlights the importance of psychological support during the 'beta wait' period, the 15 days leading up to the pregnancy test. IVI Panama highlights the role of Artificial Insemination in the treatment of couples. With personalized protocols and emotional support, IVI Panama reports cumulative success rates of over 50% after three cycles of Artificial Insemination treatment. According to Dr. Saúl Barrera, Medical Director of IVI Panama, Artificial Insemination offers encouraging results, with cumulative success rates reaching 51% when using the partner's semen and rising up to 54.8% in cases where a semen bank is required after three cycles.
